Pheiron
PrivateLast Round
VC Round
Jun 20, 2025
Momentum Score
50 /100
Company Overview
Pheiron is a biotechnology company that has developed a phenotyping platform designed to decode disease and advance new therapies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Medical AI, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pheiron Comps
Public and private peers based on sector, stage, and business model.
Pheiron Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 20, 2025 |
Key People
Founding team and executive leadership
Pheiron Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fusion Fund | VC Round |
| Compound | VC Round |
| Ananda Ventures | VC Round |
| Hummingbird Ventures | VC Round |
Pheiron Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pheiron's valuation, stock price, and market status.
